Probiotics and Biomarkers in Irritable Bowel Syndrome | MicrobiomeTrials← Back to trialsNCT07584278
Probiotics and Biomarkers in Irritable Bowel Syndrome
RecruitingNAINTERVENTIONAL
Trial Details
Start: 2026-04-28Est. Completion: 2031-04
Enrollment target: 252 participants Locations- Mag-tarmlab, Sahlgrenska University Hospital, Gothenburg, Sweden
Other microbiome trials you might be interested in
Irritable Bowel Syndrome
Irritable Bowel Syndrome (IBS), characterized by the Rome IV criteria, is a functional bowel disorder combining abdomina…
Lyon, FranceEst. completion Oct 10, 2028
Intestinal Disease
The gut microbiota plays a crucial role in human health, influencing metabolism, immunity, and pathogen resistance. Rese…
Rome, ItalyEst. completion Mar 10, 2027
Irritable bowel syndrome (IBS) is a common functional gastrointestinal disorder that substantially affects quality of li…
Istanbul, Turkey (Türkiye)Completed Nov 25, 2021